Insider Trading & Ownership of Christine A. Pellizzari

Location
Lawrenceville, NJ
Summary
The estimated net worth of Christine A. Pellizzari is at least $5,574,690 dollars as of 18 Mar 2026. Christine A. Pellizzari is the Chief Legal Officer of INSMED Inc and owns shares of INSMED Inc (INSM) stock worth about $5.47M. Christine A. Pellizzari is the Director of NeuroSense Therapeutics Ltd. and owns shares of NeuroSense Therapeutics Ltd. (NRSN) stock worth about $87.9K. Christine A. Pellizzari is the Director of Imunon, Inc. and owns shares of Imunon, Inc. (IMNN) stock worth about $20.7K.
Signature
/s/ Christine Pellizzari
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christine A. Pellizzari and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Christine A. Pellizzari has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,574,690.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: INSMED Inc ($5,466,099).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christine A. Pellizzari

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INSM INSMED Inc Chief Legal Officer $5,466,099 15 May 2021
NRSN, NRSNW NeuroSense Therapeutics Ltd. Director $87,910 18 Mar 2026
IMNN Imunon, Inc. Director $20,681 02 Jan 2026
SNCE Science 37 Holdings, Inc. Chief Legal and HR Officer $0 12 Mar 2024
TPST Tempest Therapeutics, Inc. Director 27 Jan 2026

Insider Transactions Reported by Christine A. Pellizzari:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .